Congrats to our client Repair Biotechnologies on raising over $1.2m from notable angel investors to accelerate the development of novel therapeutics to reverse atherosclerosis (arterial plaque) and atrophy of the thymus. Repair Biotechnologies is a resident of the Central New York Biotech Accelerator in Syracuse, New York.
One of our specialties at Newman & Lickstein, LLP is helping life science & biotechnology professionals navigate through the pivotal moments of their corporate lifecycle to achieve their most critical business and legal goals.
